HashiCorp, Inc.

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, MSFT has a market cap of 3.8T. Regarding current trading prices, HCP is priced at $34.78, while MSFT trades at $513.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas MSFT's P/E ratio is 39.73. In terms of profitability, HCP's ROE is -0.10%, compared to MSFT's ROE of +0.33%. Regarding short-term risk, HCP is less volatile compared to MSFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MSFT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ORCL has a market cap of 688.4B. Regarding current trading prices, HCP is priced at $34.78, while ORCL trades at $245.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ORCL's P/E ratio is 56.60. In terms of profitability, HCP's ROE is -0.10%, compared to ORCL's ROE of +0.81%. Regarding short-term risk, HCP is less volatile compared to ORCL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ORCL's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PLTR has a market cap of 359.4B. Regarding current trading prices, HCP is priced at $34.78, while PLTR trades at $158.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PLTR's P/E ratio is 690.43. In terms of profitability, HCP's ROE is -0.10%, compared to PLTR's ROE of +0.12%. Regarding short-term risk, HCP is less volatile compared to PLTR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLTR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ADBE has a market cap of 157.3B. Regarding current trading prices, HCP is priced at $34.78, while ADBE trades at $370.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ADBE's P/E ratio is 23.75. In terms of profitability, HCP's ROE is -0.10%, compared to ADBE's ROE of +0.52%. Regarding short-term risk, HCP is less volatile compared to ADBE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ADBE's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PANW has a market cap of 135.5B. Regarding current trading prices, HCP is priced at $34.78, while PANW trades at $203.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PANW's P/E ratio is 117.50. In terms of profitability, HCP's ROE is -0.10%, compared to PANW's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to PANW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PANW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWD has a market cap of 116.6B. Regarding current trading prices, HCP is priced at $34.78, while CRWD trades at $467.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CRWD's P/E ratio is -677.93. In terms of profitability, HCP's ROE is -0.10%, compared to CRWD's ROE of -0.05%. Regarding short-term risk, HCP is less volatile compared to CRWD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SNPS has a market cap of 111.3B. Regarding current trading prices, HCP is priced at $34.78, while SNPS trades at $601.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SNPS's P/E ratio is 69.46. In terms of profitability, HCP's ROE is -0.10%, compared to SNPS's ROE of +0.24%. Regarding short-term risk, HCP is less volatile compared to SNPS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SNPS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, HOOD has a market cap of 92.5B. Regarding current trading prices, HCP is priced at $34.78, while HOOD trades at $104.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas HOOD's P/E ratio is 59.91. In terms of profitability, HCP's ROE is -0.10%, compared to HOOD's ROE of +0.21%. Regarding short-term risk, HCP is less volatile compared to HOOD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check HOOD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FTNT has a market cap of 80.2B. Regarding current trading prices, HCP is priced at $34.78, while FTNT trades at $104.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FTNT's P/E ratio is 43.14. In terms of profitability, HCP's ROE is -0.10%, compared to FTNT's ROE of +1.62%. Regarding short-term risk, HCP is less volatile compared to FTNT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FTNT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NET has a market cap of 68.8B. Regarding current trading prices, HCP is priced at $34.78, while NET trades at $198.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NET's P/E ratio is -793.80. In terms of profitability, HCP's ROE is -0.10%, compared to NET's ROE of -0.08%. Regarding short-term risk, HCP is less volatile compared to NET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NET's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, HCP is priced at $34.78, while VMW trades at $142.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas VMW's P/E ratio is 42.92. In terms of profitability, HCP's ROE is -0.10%, compared to VMW's ROE of +3.99%. Regarding short-term risk, HCP is less volatile compared to VMW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VMW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CRWV has a market cap of 56.4B. Regarding current trading prices, HCP is priced at $34.78, while CRWV trades at $115.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CRWV's P/E ratio is -45.70. In terms of profitability, HCP's ROE is -0.10%, compared to CRWV's ROE of -0.91%. Regarding short-term risk, HCP is less volatile compared to CRWV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CRWV's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, HCP is priced at $34.78, while SQ trades at $83.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SQ's P/E ratio is 49.98. In terms of profitability, HCP's ROE is -0.10%, compared to SQ's ROE of +0.13%. Regarding short-term risk, HCP is less volatile compared to SQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, XYZ has a market cap of 49.7B. Regarding current trading prices, HCP is priced at $34.78, while XYZ trades at $80.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas XYZ's P/E ratio is 19.59. In terms of profitability, HCP's ROE is -0.10%, compared to XYZ's ROE of +0.13%. Regarding short-term risk, HCP is less volatile compared to XYZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check XYZ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ZS has a market cap of 44.6B. Regarding current trading prices, HCP is priced at $34.78, while ZS trades at $286.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ZS's P/E ratio is -1100.71. In terms of profitability, HCP's ROE is -0.10%, compared to ZS's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to ZS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, VRSN has a market cap of 28.7B. Regarding current trading prices, HCP is priced at $34.78, while VRSN trades at $305.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas VRSN's P/E ratio is 36.53. In terms of profitability, HCP's ROE is -0.10%, compared to VRSN's ROE of -0.55%. Regarding short-term risk, HCP is less volatile compared to VRSN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRSN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TOST has a market cap of 28.2B. Regarding current trading prices, HCP is priced at $34.78, while TOST trades at $48.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TOST's P/E ratio is 180.48. In terms of profitability, HCP's ROE is -0.10%, compared to TOST's ROE of +0.11%. Regarding short-term risk, HCP is less volatile compared to TOST. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TOST's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, HCP is priced at $34.78, while NETE trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NETE's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.10%, compared to NETE's ROE of -1.70%. Regarding short-term risk, HCP is less volatile compared to NETE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NETE's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, HCP is priced at $34.78, while SPLK trades at $156.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SPLK's P/E ratio is 103.22. In terms of profitability, HCP's ROE is -0.10%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, HCP is more volatile compared to SPLK. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SPLK's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CHKP has a market cap of 23.8B. Regarding current trading prices, HCP is priced at $34.78, while CHKP trades at $220.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CHKP's P/E ratio is 29.07. In terms of profitability, HCP's ROE is -0.10%, compared to CHKP's ROE of +0.30%. Regarding short-term risk, HCP is less volatile compared to CHKP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CHKP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CPAY has a market cap of 23.7B. Regarding current trading prices, HCP is priced at $34.78, while CPAY trades at $335.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CPAY's P/E ratio is 23.58. In terms of profitability, HCP's ROE is -0.10%, compared to CPAY's ROE of +0.33%. Regarding short-term risk, HCP is less volatile compared to CPAY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CPAY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GDDY has a market cap of 23.7B. Regarding current trading prices, HCP is priced at $34.78, while GDDY trades at $165.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GDDY's P/E ratio is 31.92. In terms of profitability, HCP's ROE is -0.10%, compared to GDDY's ROE of +2.15%. Regarding short-term risk, HCP is less volatile compared to GDDY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GDDY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, IOT has a market cap of 22.2B. Regarding current trading prices, HCP is priced at $34.78, while IOT trades at $38.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas IOT's P/E ratio is -177.18. In terms of profitability, HCP's ROE is -0.10%, compared to IOT's ROE of -0.12%. Regarding short-term risk, HCP is less volatile compared to IOT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check IOT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, HCP is priced at $34.78, while FLT trades at $303.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FLT's P/E ratio is 22.97. In terms of profitability, HCP's ROE is -0.10%, compared to FLT's ROE of +0.33%. Regarding short-term risk, HCP is less volatile compared to FLT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FLT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AFRM has a market cap of 21.6B. Regarding current trading prices, HCP is priced at $34.78, while AFRM trades at $67.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AFRM's P/E ratio is -353.11. In terms of profitability, HCP's ROE is -0.10%, compared to AFRM's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to AFRM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AFRM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NTNX has a market cap of 20B. Regarding current trading prices, HCP is priced at $34.78, while NTNX trades at $74.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NTNX's P/E ratio is -287.27. In terms of profitability, HCP's ROE is -0.10%, compared to NTNX's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to NTNX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTNX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, MDB has a market cap of 19.7B. Regarding current trading prices, HCP is priced at $34.78, while MDB trades at $241.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas MDB's P/E ratio is -223.49. In terms of profitability, HCP's ROE is -0.10%, compared to MDB's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to MDB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MDB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CYBR has a market cap of 19B. Regarding current trading prices, HCP is priced at $34.78, while CYBR trades at $378.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CYBR's P/E ratio is -186.56. In terms of profitability, HCP's ROE is -0.10%, compared to CYBR's ROE of -0.05%. Regarding short-term risk, HCP is less volatile compared to CYBR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CYBR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GEN has a market cap of 19B. Regarding current trading prices, HCP is priced at $34.78, while GEN trades at $30.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GEN's P/E ratio is 29.72. In terms of profitability, HCP's ROE is -0.10%, compared to GEN's ROE of +0.30%. Regarding short-term risk, HCP is less volatile compared to GEN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GEN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FFIV has a market cap of 17.2B. Regarding current trading prices, HCP is priced at $34.78, while FFIV trades at $299.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FFIV's P/E ratio is 28.46. In terms of profitability, HCP's ROE is -0.10%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to FFIV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FFIV's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, OKTA has a market cap of 16.9B. Regarding current trading prices, HCP is priced at $34.78, while OKTA trades at $101.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas OKTA's P/E ratio is 155.54. In terms of profitability, HCP's ROE is -0.10%, compared to OKTA's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to OKTA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check OKTA's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RBRK has a market cap of 16.4B. Regarding current trading prices, HCP is priced at $34.78, while RBRK trades at $85.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RBRK's P/E ratio is 24.51. In terms of profitability, HCP's ROE is -0.10%, compared to RBRK's ROE of +0.99%. Regarding short-term risk, HCP is less volatile compared to RBRK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RBRK's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, KSPI has a market cap of 16.2B. Regarding current trading prices, HCP is priced at $34.78, while KSPI trades at $85.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas KSPI's P/E ratio is 8.08. In terms of profitability, HCP's ROE is -0.10%, compared to KSPI's ROE of +0.75%. Regarding short-term risk, HCP is less volatile compared to KSPI. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KSPI's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, HCP is priced at $34.78, while NLOK trades at $21.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NLOK's P/E ratio is 15.15. In terms of profitability, HCP's ROE is -0.10%, compared to NLOK's ROE of +0.30%. Regarding short-term risk, HCP is less volatile compared to NLOK. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NLOK's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AKAM has a market cap of 11.8B. Regarding current trading prices, HCP is priced at $34.78, while AKAM trades at $80.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AKAM's P/E ratio is 27.10. In terms of profitability, HCP's ROE is -0.10%, compared to AKAM's ROE of +0.10%. Regarding short-term risk, HCP is less volatile compared to AKAM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AKAM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SAIL has a market cap of 11.3B. Regarding current trading prices, HCP is priced at $34.78, while SAIL trades at $20.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SAIL's P/E ratio is -12.42. In terms of profitability, HCP's ROE is -0.10%, compared to SAIL's ROE of -0.30%. Regarding short-term risk, HCP is less volatile compared to SAIL. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SAIL's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DOX has a market cap of 9.8B. Regarding current trading prices, HCP is priced at $34.78, while DOX trades at $87.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DOX's P/E ratio is 18.46. In terms of profitability, HCP's ROE is -0.10%, compared to DOX's ROE of +0.16%. Regarding short-term risk, HCP is less volatile compared to DOX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while ALTR trades at $111.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ALTR's P/E ratio is 699.06. In terms of profitability, HCP's ROE is -0.10%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, HCP is more volatile compared to ALTR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check ALTR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FOUR has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while FOUR trades at $106.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FOUR's P/E ratio is 36.56. In terms of profitability, HCP's ROE is -0.10%, compared to FOUR's ROE of +0.29%. Regarding short-term risk, HCP is less volatile compared to FOUR. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FOUR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, HCP is priced at $34.78, while PLAN trades at $63.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PLAN's P/E ratio is -44.82. In terms of profitability, HCP's ROE is -0.10%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, HCP is less volatile compared to PLAN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PLAN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CFLT has a market cap of 9.3B. Regarding current trading prices, HCP is priced at $34.78, while CFLT trades at $27.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CFLT's P/E ratio is -28.20. In terms of profitability, HCP's ROE is -0.10%, compared to CFLT's ROE of -0.34%. Regarding short-term risk, HCP is less volatile compared to CFLT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CFLT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, KVYO has a market cap of 9.1B. Regarding current trading prices, HCP is priced at $34.78, while KVYO trades at $33.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas KVYO's P/E ratio is -194.53. In terms of profitability, HCP's ROE is -0.10%, compared to KVYO's ROE of -0.05%. Regarding short-term risk, HCP is less volatile compared to KVYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check KVYO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, INFA has a market cap of 8.6B. Regarding current trading prices, HCP is priced at $34.78, while INFA trades at $24.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas INFA's P/E ratio is 820.17. In terms of profitability, HCP's ROE is -0.10%, compared to INFA's ROE of +0.00%. Regarding short-term risk, HCP is less volatile compared to INFA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check INFA's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, WIX has a market cap of 8.5B. Regarding current trading prices, HCP is priced at $34.78, while WIX trades at $152.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas WIX's P/E ratio is 60.75. In terms of profitability, HCP's ROE is -0.10%, compared to WIX's ROE of -0.77%. Regarding short-term risk, HCP is less volatile compared to WIX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WIX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DBX has a market cap of 7.8B. Regarding current trading prices, HCP is priced at $34.78, while DBX trades at $27.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DBX's P/E ratio is 18.27. In terms of profitability, HCP's ROE is -0.10%, compared to DBX's ROE of -0.69%. Regarding short-term risk, HCP is less volatile compared to DBX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DBX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, HCP is priced at $34.78, while JCOM trades at $142.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas JCOM's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.10%, compared to JCOM's ROE of +0.04%. Regarding short-term risk, HCP is less volatile compared to JCOM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check JCOM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CCCS has a market cap of 6.6B. Regarding current trading prices, HCP is priced at $34.78, while CCCS trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CCCS's P/E ratio is 1002.00. In terms of profitability, HCP's ROE is -0.10%, compared to CCCS's ROE of +0.00%. Regarding short-term risk, HCP is less volatile compared to CCCS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CCCS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PATH has a market cap of 6.5B. Regarding current trading prices, HCP is priced at $34.78, while PATH trades at $12.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PATH's P/E ratio is -101.46. In terms of profitability, HCP's ROE is -0.10%, compared to PATH's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to PATH. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PATH's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, HCP is priced at $34.78, while SQSP trades at $46.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, HCP's ROE is -0.10%, compared to SQSP's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to SQSP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SQSP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, S has a market cap of 6.2B. Regarding current trading prices, HCP is priced at $34.78, while S trades at $19.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas S's P/E ratio is -14.82. In terms of profitability, HCP's ROE is -0.10%, compared to S's ROE of -0.26%. Regarding short-term risk, HCP is less volatile compared to S. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check S's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, HCP is priced at $34.78, while NEWR trades at $86.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NEWR's P/E ratio is -41.62. In terms of profitability, HCP's ROE is -0.10%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, HCP is more volatile compared to NEWR. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NEWR's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, VRNS has a market cap of 6.1B. Regarding current trading prices, HCP is priced at $34.78, while VRNS trades at $54.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas VRNS's P/E ratio is -67.52. In terms of profitability, HCP's ROE is -0.10%, compared to VRNS's ROE of -0.21%. Regarding short-term risk, HCP is less volatile compared to VRNS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check VRNS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, WEX has a market cap of 6B. Regarding current trading prices, HCP is priced at $34.78, while WEX trades at $175.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas WEX's P/E ratio is 22.21. In terms of profitability, HCP's ROE is -0.10%, compared to WEX's ROE of +0.22%. Regarding short-term risk, HCP is less volatile compared to WEX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WEX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SPSC has a market cap of 5.2B. Regarding current trading prices, HCP is priced at $34.78, while SPSC trades at $136.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SPSC's P/E ratio is 63.78. In terms of profitability, HCP's ROE is -0.10%, compared to SPSC's ROE of +0.10%. Regarding short-term risk, HCP is less volatile compared to SPSC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check SPSC's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, QLYS has a market cap of 5B. Regarding current trading prices, HCP is priced at $34.78, while QLYS trades at $136.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas QLYS's P/E ratio is 28.03. In terms of profitability, HCP's ROE is -0.10%, compared to QLYS's ROE of +0.39%. Regarding short-term risk, HCP is less volatile compared to QLYS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check QLYS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, HCP is priced at $34.78, while NVEI trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NVEI's P/E ratio is 212.44. In terms of profitability, HCP's ROE is -0.10%, compared to NVEI's ROE of +0.01%. Regarding short-term risk, HCP is more volatile compared to NVEI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check NVEI's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, BOX has a market cap of 4.8B. Regarding current trading prices, HCP is priced at $34.78, while BOX trades at $32.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas BOX's P/E ratio is 25.38. In terms of profitability, HCP's ROE is -0.10%, compared to BOX's ROE of +1.97%. Regarding short-term risk, HCP is less volatile compared to BOX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BOX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ACIW has a market cap of 4.7B. Regarding current trading prices, HCP is priced at $34.78, while ACIW trades at $44.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ACIW's P/E ratio is 17.71. In terms of profitability, HCP's ROE is -0.10%, compared to ACIW's ROE of +0.20%. Regarding short-term risk, HCP is less volatile compared to ACIW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ACIW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EEFT has a market cap of 4.5B. Regarding current trading prices, HCP is priced at $34.78, while EEFT trades at $103.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EEFT's P/E ratio is 15.37. In terms of profitability, HCP's ROE is -0.10%, compared to EEFT's ROE of +0.25%. Regarding short-term risk, HCP is less volatile compared to EEFT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EEFT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZZ has a market cap of 4.2B. Regarding current trading prices, HCP is priced at $34.78, while CORZZ trades at $13.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CORZZ's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.10%, compared to CORZZ's ROE of +1.34%. Regarding short-term risk, HCP is less volatile compared to CORZZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZZ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZ has a market cap of 4.2B. Regarding current trading prices, HCP is priced at $34.78, while CORZ trades at $13.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CORZ's P/E ratio is -3.51. In terms of profitability, HCP's ROE is -0.10%, compared to CORZ's ROE of +1.34%. Regarding short-term risk, HCP is less volatile compared to CORZ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TENB has a market cap of 4.1B. Regarding current trading prices, HCP is priced at $34.78, while TENB trades at $33.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TENB's P/E ratio is -87.39. In terms of profitability, HCP's ROE is -0.10%, compared to TENB's ROE of -0.12%. Regarding short-term risk, HCP is less volatile compared to TENB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TENB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AVPT has a market cap of 3.9B. Regarding current trading prices, HCP is priced at $34.78, while AVPT trades at $18.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AVPT's P/E ratio is -142.77. In terms of profitability, HCP's ROE is -0.10%, compared to AVPT's ROE of -0.09%. Regarding short-term risk, HCP is less volatile compared to AVPT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AVPT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, HCP is priced at $34.78, while ESMT trades at $23.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ESMT's P/E ratio is 153.67. In terms of profitability, HCP's ROE is -0.10%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, HCP is less volatile compared to ESMT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ESMT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ODD has a market cap of 3.8B. Regarding current trading prices, HCP is priced at $34.78, while ODD trades at $67.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ODD's P/E ratio is 39.02. In terms of profitability, HCP's ROE is -0.10%, compared to ODD's ROE of +0.32%. Regarding short-term risk, HCP is less volatile compared to ODD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ODD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, STNE has a market cap of 3.6B. Regarding current trading prices, HCP is priced at $34.78, while STNE trades at $13.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas STNE's P/E ratio is -16.94. In terms of profitability, HCP's ROE is -0.10%, compared to STNE's ROE of -0.10%. Regarding short-term risk, HCP is less volatile compared to STNE. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STNE's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RELY has a market cap of 3.5B. Regarding current trading prices, HCP is priced at $34.78, while RELY trades at $16.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RELY's P/E ratio is -566.00. In terms of profitability, HCP's ROE is -0.10%, compared to RELY's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to RELY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RELY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CLBT has a market cap of 3.4B. Regarding current trading prices, HCP is priced at $34.78, while CLBT trades at $14.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CLBT's P/E ratio is -15.57. In terms of profitability, HCP's ROE is -0.10%, compared to CLBT's ROE of -0.81%. Regarding short-term risk, HCP is less volatile compared to CLBT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CLBT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, HCP is priced at $34.78, while SWI trades at $18.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SWI's P/E ratio is 28.89. In terms of profitability, HCP's ROE is -0.10%, compared to SWI's ROE of +0.08%. Regarding short-term risk, HCP is more volatile compared to SWI. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SWI's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DLO has a market cap of 3.1B. Regarding current trading prices, HCP is priced at $34.78, while DLO trades at $10.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DLO's P/E ratio is 22.56. In terms of profitability, HCP's ROE is -0.10%, compared to DLO's ROE of +0.31%. Regarding short-term risk, HCP is less volatile compared to DLO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DLO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, HCP is priced at $34.78, while EVOP trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EVOP's P/E ratio is -309.00. In terms of profitability, HCP's ROE is -0.10%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, HCP is less volatile compared to EVOP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVOP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, WRD has a market cap of 2.9B. Regarding current trading prices, HCP is priced at $34.78, while WRD trades at $10.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas WRD's P/E ratio is -8.69. In terms of profitability, HCP's ROE is -0.10%, compared to WRD's ROE of -1.69%. Regarding short-term risk, HCP is less volatile compared to WRD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check WRD's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, MQ has a market cap of 2.7B. Regarding current trading prices, HCP is priced at $34.78, while MQ trades at $5.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas MQ's P/E ratio is 57.90. In terms of profitability, HCP's ROE is -0.10%, compared to MQ's ROE of +0.05%. Regarding short-term risk, HCP is less volatile compared to MQ. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check MQ's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PAGS has a market cap of 2.7B. Regarding current trading prices, HCP is priced at $34.78, while PAGS trades at $8.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PAGS's P/E ratio is 6.63. In terms of profitability, HCP's ROE is -0.10%, compared to PAGS's ROE of +0.15%. Regarding short-term risk, HCP is less volatile compared to PAGS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAGS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, DOCN has a market cap of 2.6B. Regarding current trading prices, HCP is priced at $34.78, while DOCN trades at $28.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas DOCN's P/E ratio is 25.50. In terms of profitability, HCP's ROE is -0.10%, compared to DOCN's ROE of -0.49%. Regarding short-term risk, HCP is less volatile compared to DOCN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check DOCN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PGYWW has a market cap of 2.5B. Regarding current trading prices, HCP is priced at $34.78, while PGYWW trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PGYWW's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.10%, compared to PGYWW's ROE of -0.90%. Regarding short-term risk, HCP is less volatile compared to PGYWW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PGYWW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PAYO has a market cap of 2.5B. Regarding current trading prices, HCP is priced at $34.78, while PAYO trades at $6.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PAYO's P/E ratio is 24.32. In terms of profitability, HCP's ROE is -0.10%, compared to PAYO's ROE of +0.16%. Regarding short-term risk, HCP is less volatile compared to PAYO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PAYO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, PGY has a market cap of 2.4B. Regarding current trading prices, HCP is priced at $34.78, while PGY trades at $31.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas PGY's P/E ratio is -6.02. In terms of profitability, HCP's ROE is -0.10%, compared to PGY's ROE of -0.90%. Regarding short-term risk, HCP is less volatile compared to PGY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check PGY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, BB has a market cap of 2.3B. Regarding current trading prices, HCP is priced at $34.78, while BB trades at $3.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas BB's P/E ratio is 195.50. In terms of profitability, HCP's ROE is -0.10%, compared to BB's ROE of -0.06%. Regarding short-term risk, HCP is less volatile compared to BB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check BB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FIVN has a market cap of 2.2B. Regarding current trading prices, HCP is priced at $34.78, while FIVN trades at $28.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FIVN's P/E ratio is -481.00. In terms of profitability, HCP's ROE is -0.10%, compared to FIVN's ROE of -0.01%. Regarding short-term risk, HCP is less volatile compared to FIVN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FIVN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, APPN has a market cap of 2.2B. Regarding current trading prices, HCP is priced at $34.78, while APPN trades at $29.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas APPN's P/E ratio is -35.67. In terms of profitability, HCP's ROE is -0.10%, compared to APPN's ROE of +1.51%. Regarding short-term risk, HCP is less volatile compared to APPN. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check APPN's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CORZW has a market cap of 2.2B. Regarding current trading prices, HCP is priced at $34.78, while CORZW trades at $7.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CORZW's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.10%, compared to CORZW's ROE of +1.34%. Regarding short-term risk, HCP is less volatile compared to CORZW. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CORZW's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RAMP has a market cap of 2.2B. Regarding current trading prices, HCP is priced at $34.78, while RAMP trades at $32.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RAMP's P/E ratio is -821.62. In terms of profitability, HCP's ROE is -0.10%, compared to RAMP's ROE of -0.00%. Regarding short-term risk, HCP is less volatile compared to RAMP. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RAMP's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EVTC has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while EVTC trades at $33.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EVTC's P/E ratio is 16.75. In terms of profitability, HCP's ROE is -0.10%, compared to EVTC's ROE of +0.26%. Regarding short-term risk, HCP is less volatile compared to EVTC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVTC's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, EVCM has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while EVCM trades at $11.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas EVCM's P/E ratio is -96.42. In terms of profitability, HCP's ROE is -0.10%, compared to EVCM's ROE of -0.04%. Regarding short-term risk, HCP is less volatile compared to EVCM. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check EVCM's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TDC has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while TDC trades at $22.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TDC's P/E ratio is 15.65. In terms of profitability, HCP's ROE is -0.10%, compared to TDC's ROE of +1.12%. Regarding short-term risk, HCP is less volatile compared to TDC. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TDC's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, HCP is priced at $34.78, while GETVV trades at $2.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GETVV's P/E ratio is N/A. In terms of profitability, HCP's ROE is -0.10%, compared to GETVV's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GETVV. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GETVV's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, AVDX has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while AVDX trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas AVDX's P/E ratio is 246.75. In terms of profitability, HCP's ROE is -0.10%, compared to AVDX's ROE of +0.00%. Regarding short-term risk, HCP is less volatile compared to AVDX. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check AVDX's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, HCP is priced at $34.78, while FORG trades at $23.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas FORG's P/E ratio is -22.53. In terms of profitability, HCP's ROE is -0.10%, compared to FORG's ROE of -0.20%. Regarding short-term risk, HCP is less volatile compared to FORG. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check FORG's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, HCP is priced at $34.78, while GSKY trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GSKY's P/E ratio is 18.61. In terms of profitability, HCP's ROE is -0.10%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, HCP is less volatile compared to GSKY. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GSKY's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, CSGS has a market cap of 1.8B. Regarding current trading prices, HCP is priced at $34.78, while CSGS trades at $62.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas CSGS's P/E ratio is 21.27. In terms of profitability, HCP's ROE is -0.10%, compared to CSGS's ROE of +0.30%. Regarding short-term risk, HCP is less volatile compared to CSGS. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check CSGS's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, HCP is priced at $34.78, while GET trades at $1.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GET's P/E ratio is 31.33. In terms of profitability, HCP's ROE is -0.10%, compared to GET's ROE of N/A. Regarding short-term risk, HCP is less volatile compared to GET. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GET's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while STER trades at $16.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas STER's P/E ratio is -98.47. In terms of profitability, HCP's ROE is -0.10%, compared to STER's ROE of -0.02%. Regarding short-term risk, HCP is less volatile compared to STER. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check STER's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, NTCT has a market cap of 1.6B. Regarding current trading prices, HCP is priced at $34.78, while NTCT trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas NTCT's P/E ratio is -4.35. In terms of profitability, HCP's ROE is -0.10%, compared to NTCT's ROE of -0.33%. Regarding short-term risk, HCP is less volatile compared to NTCT. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check NTCT's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while ZUO trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas ZUO's P/E ratio is -19.65. In terms of profitability, HCP's ROE is -0.10%, compared to ZUO's ROE of -0.46%. Regarding short-term risk, HCP is less volatile compared to ZUO. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check ZUO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, TUYA has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while TUYA trades at $2.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas TUYA's P/E ratio is 62.25. In terms of profitability, HCP's ROE is -0.10%, compared to TUYA's ROE of +0.02%. Regarding short-term risk, HCP is less volatile compared to TUYA. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check TUYA's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while SUMO trades at $12.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas SUMO's P/E ratio is -11.36. In terms of profitability, HCP's ROE is -0.10%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, HCP is more volatile compared to SUMO. This indicates potentially higher risk in terms of short-term price fluctuations for HCP.Check SUMO's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, GB has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while GB trades at $7.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas GB's P/E ratio is 17.98. In terms of profitability, HCP's ROE is -0.10%, compared to GB's ROE of +0.76%. Regarding short-term risk, HCP is less volatile compared to GB. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check GB's competition here

HCP plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HCP stands at 7.1B. In comparison, RPD has a market cap of 1.5B. Regarding current trading prices, HCP is priced at $34.78, while RPD trades at $22.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HCP currently has a P/E ratio of -57.97, whereas RPD's P/E ratio is 55.39. In terms of profitability, HCP's ROE is -0.10%, compared to RPD's ROE of +9.05%. Regarding short-term risk, HCP is less volatile compared to RPD. This indicates potentially lower risk in terms of short-term price fluctuations for HCP.Check RPD's competition here